Race Against Time of Validation Study of Trisomy 21 Diagnostic Test II
Sequenom announced this week that they have entered into a supply agreement with Illumina for sequencing equipment and consumables. They will purchase the Illumina products for use in developing its non-invasive trisomy 21 test.
Sequenom plan to launch its SensiGene T21 test as a laboratory-developed test at the end of 2011 or in Q1 2012. The company also had previously disclosed that it had completed a validation study of its test on the Illumina HiSeq platform in 2,000 high-risk pregnancies, which will serve as the basis for the LDT.
It keeps exciting what GATC and Verinata are doing (resp. launching) in the meanwhile…